EFL

Cohort Year: 2021-2022

Tracks: Life Sciences

VISIT WEBSITE

Immunyx Pharma

Immunyx has developed targeted neutrophil nanoparticles (TENNs) to solve the major hurdles in treating neutrophils in disease, with a focus on therapies for colitis and cancer.